
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Antibiotic Resistance and New Antimicrobial drugs
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1545999
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: This study assessed epidemiology characteristics, carbapenem-resistance genes, and drug resistance to ceftazidime-avibactam (CZA) and aztreonam-avibactam (AZA) in children with carbapenem-resistant Klebsiella Pneumoniae (CRKP) infections.: A total of 363 non-repetitive CRKP strains were collected from children who underwent two tertiary children's hospital between 1 January 2021 and 30 June 2024 in Chongqing and Kunming in Southwest China. Carbapenem resistance genes and antimicrobial susceptibility were analyzed. Basic clinical characteristics of the patients were obtained from medical records. Carbapenem-Resistant Klebsiella pneumoniae Infections in Chinese Children: In Vitro Activities of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Carbapenemase-Producing Strains in a Two-Center Study 删除[Chunmei Jing]:Results: blaNDM-5, blaNDM-1, and blaKPC-2 were the predominant carbapenemase genes; their detection rates were 35.8%, 30.3%, and 25.3%, respectively. Patients in the KPC-2-producing Klebsiella pneumoniae (KPC-KP) (median age, 90 days) were older than those producing NDM-1 and NDM-5 Klebsiella pneumoniae (NDM-KP) (median age, 37 days) (P < 0.05). The detection rate of NDM-KP in the neonatal unit was higher compared with KPC-KP (62.5% vs. 9.8%, P < 0.05), while the detection rate of NDM-KP in the intensive care unit (ICU) was decreased compared with KPC-KP (9.6% vs. 40.2%, P < 0.05). NDM-KP had lower resistance rates to aminoglycosides and fluoroquinolones than KPC-KP; the resistance rate of aminoglycosides and fluoroquinolones among NDM-KP and KPC-KP in Chongqing was increased compared with Kunming. The sensitivity rates of KPC-KP to CZA and NDM-KP to AZA were 100%, and the MIC50 of the CRKP to CZA and AZA were 2 μg/mL and 0.125μg/mL, respectively.The epidemiological characteristics of Chinese children with CRKP infections, including the resistance genes and the antibiotic resistance of CRKP, exhibited significant variation between the two regions.KPC-KP strains had higher antimicrobial resistance in patients and thus should be given more attention in clinics and infection control.
Keywords: carbapenem-resistant Klebsiella pneumoniae, Ceftazidime-avibactam, Aztreonam-avibactam, KPC-2, NDM-1 and NDM-5, epidemiology characteristics, Paediatric patient
Received: 16 Dec 2024; Accepted: 17 Feb 2025.
Copyright: © 2025 Chunmei, Wang, Ran, Chen, Wang and Xie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jing Chunmei, Children‘s Hospital of Chongqing Medical University, Chongqing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.